Skip to main content
Clinical Trials/NCT05332288
NCT05332288
Recruiting
Not Applicable

Triphasic Osteochondral Scaffold for the Treatment of Osteochondritis Dissecans of the Knee: Observational Study

Istituto Ortopedico Rizzoli1 site in 1 country30 target enrollmentApril 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteochondritis Dissecans Knee
Sponsor
Istituto Ortopedico Rizzoli
Enrollment
30
Locations
1
Primary Endpoint
IKDC-Subjective Score
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The objective of the present study is to evaluate the clinical results of reconstructive treatment of knee OCD defects treated with osteochondral scaffolds implanted with specific instrumentation.The evaluation will be performed through clinical, subjective and objective assessments.

Detailed Description

30 patients affected by OCD of the knee will be included in observational, perspective, monocentric trial. Patients will undergo clinical follow-up visits and administration of questionnaires before surgery and at 6, 12, 24 and 60 months after surgery. A CRF (Case Report Form) related to the patient's specific evaluation will be completed for each visit. Patients will also have imaging (MRI) examinations before surgery and at 12, 24 and 60 months after surgery as per normal clinical practice. Evaluation of the quality of cartilage repair will be assessed by specific MRI radiographic scores.

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
April 1, 2029
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • -Additional grade III or IV cartilage injury on the knee being treated;
  • Advanced osteoarthritis
  • Systemic or localized infection
  • Systemic (e.g. rheumatoid arthritis) or local (e.g. synovitis) inflammatory diseases and cardiovascular diseases
  • Immune system disorders
  • Degenerative or vascular bone pathology (e.g. osteonecrosis)
  • Coagulation disorders
  • Systemic conditions that alter wound healing
  • Established allergy to equine collagen and calcium phosphate salts
  • Presence of ligamentous/patellofemoral instability/malignment, varus or valgus malalignment ≤ 3° that cannot be treated/corrected simultaneously;

Outcomes

Primary Outcomes

IKDC-Subjective Score

Time Frame: 24 months

This is a subjective, knee-specific rating scale that is considered one of the most reliable assessment tools in the evaluation of knee pathologies. All questions examines 3 categories: symptoms, sports activity, and knee function

Secondary Outcomes

  • IKDC-Subjective Score(baseline, 6 months, 12 months, 60 months)
  • IKDC-Objective Score(baseline, 6 months, 12 months, 24 months, 60 months)
  • EQ-5D (EuroQoL) Current Health Assessment(baseline, 6 months, 12 months, 24 months, 60 months)
  • TegnerActivity Level Scale(baseline, 6 months, 12 months, 24 months, 60 months)
  • Patient Acceptable Symptom State (PASS(baseline, 6 months, 12 months, 24 months, 60 months)
  • KOOS Score(baseline, 6 months, 12 months, 24 months, 60 months)
  • Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score(12 months, 24 months, 60 months)

Study Sites (1)

Loading locations...

Similar Trials